Elan Eisenmesser
Concepts (384)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus pneumoniae | 7 | 2026 | 187 | 4.050 |
Why?
| | Bacterial Proteins | 11 | 2026 | 976 | 2.930 |
Why?
| | Cyclophilin A | 13 | 2017 | 27 | 2.360 |
Why?
| | Catalytic Domain | 13 | 2026 | 234 | 2.160 |
Why?
| | Serine Endopeptidases | 4 | 2026 | 129 | 2.150 |
Why?
| | Virulence Factors | 4 | 2026 | 175 | 2.080 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 3 | 2024 | 27 | 2.030 |
Why?
| | Serine Proteases | 2 | 2026 | 26 | 1.820 |
Why?
| | Models, Molecular | 29 | 2026 | 1571 | 1.640 |
Why?
| | Basigin | 5 | 2017 | 24 | 1.590 |
Why?
| | Cyclophilins | 7 | 2023 | 40 | 1.490 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 22 | 2020 | 348 | 1.430 |
Why?
| | Protein Conformation | 19 | 2026 | 914 | 1.390 |
Why?
| | Interleukin-1 | 10 | 2024 | 960 | 1.350 |
Why?
| | Staphylococcus aureus | 3 | 2026 | 458 | 1.040 |
Why?
| | Aminoacyltransferases | 1 | 2026 | 13 | 0.970 |
Why?
| | Cysteine Endopeptidases | 1 | 2026 | 80 | 0.950 |
Why?
| | Molecular Dynamics Simulation | 6 | 2026 | 267 | 0.940 |
Why?
| | Protein Binding | 19 | 2026 | 2239 | 0.930 |
Why?
| | Thermodynamics | 3 | 2020 | 418 | 0.910 |
Why?
| | Mutation | 6 | 2025 | 4082 | 0.800 |
Why?
| | Evolution, Molecular | 2 | 2024 | 501 | 0.770 |
Why?
| | Coenzymes | 2 | 2024 | 23 | 0.760 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2026 | 253 | 0.760 |
Why?
| | Metalloproteases | 1 | 2022 | 42 | 0.740 |
Why?
| | Substrate Specificity | 5 | 2026 | 387 | 0.690 |
Why?
| | Crystallography, X-Ray | 12 | 2025 | 477 | 0.670 |
Why?
| | Immunoglobulin A | 1 | 2022 | 205 | 0.670 |
Why?
| | Bacteria | 4 | 2023 | 766 | 0.650 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 129 | 0.620 |
Why?
| | Protease Inhibitors | 1 | 2020 | 103 | 0.620 |
Why?
| | Catalysis | 12 | 2024 | 304 | 0.600 |
Why?
| | Allosteric Regulation | 4 | 2026 | 100 | 0.600 |
Why?
| | Magnetic Resonance Spectroscopy | 9 | 2019 | 627 | 0.540 |
Why?
| | Erythrocytes | 5 | 2021 | 749 | 0.520 |
Why?
| | Binding Sites | 10 | 2021 | 1306 | 0.510 |
Why?
| | Protein Structure, Tertiary | 7 | 2015 | 834 | 0.500 |
Why?
| | Geobacillus | 2 | 2015 | 2 | 0.490 |
Why?
| | Valine | 1 | 2017 | 84 | 0.480 |
Why?
| | Immune Tolerance | 1 | 2019 | 384 | 0.480 |
Why?
| | Protein Structure, Secondary | 8 | 2017 | 357 | 0.480 |
Why?
| | RNA | 1 | 2023 | 925 | 0.480 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.470 |
Why?
| | Protein Folding | 5 | 2017 | 281 | 0.460 |
Why?
| | Energy Metabolism | 3 | 2021 | 930 | 0.460 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 153 | 0.450 |
Why?
| | Hemorrhagic Fever Virus, Crimean-Congo | 1 | 2015 | 13 | 0.430 |
Why?
| | Protein Multimerization | 3 | 2026 | 201 | 0.420 |
Why?
| | Receptors, Interleukin-8A | 1 | 2014 | 5 | 0.410 |
Why?
| | Interleukin-8 | 2 | 2020 | 268 | 0.410 |
Why?
| | Recombinant Proteins | 8 | 2025 | 1361 | 0.410 |
Why?
| | Peptide Hydrolases | 1 | 2015 | 105 | 0.410 |
Why?
| | Pneumococcal Infections | 2 | 2025 | 104 | 0.400 |
Why?
| | Humans | 57 | 2026 | 145625 | 0.400 |
Why?
| | Peptides | 4 | 2014 | 991 | 0.390 |
Why?
| | Immunity, Innate | 2 | 2019 | 843 | 0.390 |
Why?
| | Extracellular Space | 1 | 2013 | 118 | 0.380 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2013 | 128 | 0.370 |
Why?
| | Cryoelectron Microscopy | 2 | 2026 | 180 | 0.370 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 176 | 0.360 |
Why?
| | Temperature | 2 | 2012 | 633 | 0.360 |
Why?
| | Protein Domains | 4 | 2025 | 314 | 0.350 |
Why?
| | Interleukin-6 | 3 | 2021 | 782 | 0.350 |
Why?
| | Peptidylprolyl Isomerase | 4 | 2017 | 9 | 0.340 |
Why?
| | Blood Preservation | 3 | 2021 | 346 | 0.330 |
Why?
| | Oxidative Stress | 4 | 2025 | 1367 | 0.330 |
Why?
| | Structure-Activity Relationship | 4 | 2018 | 561 | 0.320 |
Why?
| | Interleukins | 3 | 2023 | 247 | 0.310 |
Why?
| | Enzyme Inhibitors | 3 | 2025 | 820 | 0.310 |
Why?
| | Interleukin-13 | 2 | 2001 | 149 | 0.310 |
Why?
| | Amino Acid Sequence | 10 | 2025 | 2088 | 0.310 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 2 | 2021 | 23 | 0.310 |
Why?
| | Animals | 23 | 2026 | 38030 | 0.290 |
Why?
| | Biocatalysis | 2 | 2020 | 68 | 0.280 |
Why?
| | Mice | 17 | 2026 | 18266 | 0.280 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 944 | 0.270 |
Why?
| | Oxidation-Reduction | 4 | 2025 | 1075 | 0.270 |
Why?
| | Nucleocapsid Proteins | 2 | 2023 | 28 | 0.270 |
Why?
| | Immunologic Factors | 2 | 2021 | 244 | 0.260 |
Why?
| | DNA Viruses | 1 | 2007 | 24 | 0.260 |
Why?
| | Escherichia coli Proteins | 2 | 2017 | 200 | 0.250 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 485 | 0.240 |
Why?
| | Teichoic Acids | 1 | 2026 | 21 | 0.240 |
Why?
| | Amino Acid Motifs | 2 | 2017 | 217 | 0.240 |
Why?
| | Cell Wall | 1 | 2026 | 60 | 0.240 |
Why?
| | Aurora Kinase A | 1 | 2026 | 57 | 0.240 |
Why?
| | PDZ Domains | 1 | 2026 | 12 | 0.230 |
Why?
| | Exercise Tolerance | 2 | 2019 | 288 | 0.230 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2026 | 65 | 0.230 |
Why?
| | Azepines | 1 | 2026 | 104 | 0.230 |
Why?
| | Thrombopoiesis | 1 | 2025 | 7 | 0.220 |
Why?
| | Megakaryocytes | 1 | 2025 | 34 | 0.220 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2025 | 15 | 0.220 |
Why?
| | Cell Line | 5 | 2021 | 2809 | 0.220 |
Why?
| | Anti-Inflammatory Agents | 3 | 2021 | 473 | 0.220 |
Why?
| | Peptide Fragments | 2 | 2000 | 693 | 0.220 |
Why?
| | Allosteric Site | 1 | 2024 | 17 | 0.220 |
Why?
| | Trypsin | 1 | 2025 | 73 | 0.220 |
Why?
| | Molecular Sequence Data | 7 | 2014 | 2835 | 0.220 |
Why?
| | Receptors, Interleukin-1 | 3 | 2021 | 211 | 0.220 |
Why?
| | Ligands | 4 | 2019 | 676 | 0.210 |
Why?
| | Viral Proteins | 1 | 2007 | 350 | 0.210 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 2 | 2023 | 22 | 0.210 |
Why?
| | Haemophilus | 1 | 2024 | 8 | 0.210 |
Why?
| | Corynebacterium | 1 | 2024 | 50 | 0.210 |
Why?
| | Corynebacterium Infections | 1 | 2024 | 43 | 0.200 |
Why?
| | Mammals | 2 | 2023 | 287 | 0.200 |
Why?
| | Enzyme Stability | 2 | 2015 | 74 | 0.200 |
Why?
| | Haemophilus Infections | 1 | 2024 | 45 | 0.200 |
Why?
| | Acinetobacter baumannii | 1 | 2023 | 26 | 0.200 |
Why?
| | Haemophilus influenzae | 1 | 2024 | 67 | 0.200 |
Why?
| | Antibodies, Monoclonal | 2 | 2021 | 1511 | 0.190 |
Why?
| | Bacterial Adhesion | 2 | 2024 | 109 | 0.190 |
Why?
| | Host-Pathogen Interactions | 1 | 2026 | 366 | 0.190 |
Why?
| | Nucleocapsid | 1 | 2023 | 19 | 0.190 |
Why?
| | NAD | 1 | 2023 | 80 | 0.190 |
Why?
| | Inflammation | 6 | 2021 | 2915 | 0.190 |
Why?
| | Streptococcus | 1 | 2022 | 26 | 0.180 |
Why?
| | Pyrimidines | 1 | 2026 | 530 | 0.180 |
Why?
| | Amino Acids | 2 | 2017 | 513 | 0.180 |
Why?
| | Serine | 1 | 2023 | 142 | 0.180 |
Why?
| | Blood Banks | 2 | 2021 | 50 | 0.180 |
Why?
| | NADP | 2 | 2021 | 52 | 0.180 |
Why?
| | Blood Donors | 2 | 2021 | 145 | 0.180 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 80 | 0.170 |
Why?
| | HEK293 Cells | 2 | 2021 | 746 | 0.170 |
Why?
| | Kinetics | 5 | 2015 | 1553 | 0.170 |
Why?
| | Arginine | 1 | 2023 | 263 | 0.170 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 211 | 0.170 |
Why?
| | Receptors, Interleukin | 1 | 2001 | 43 | 0.170 |
Why?
| | Receptors, Interleukin-18 | 1 | 2021 | 17 | 0.170 |
Why?
| | Spinal Cord | 2 | 2021 | 378 | 0.170 |
Why?
| | Protein Renaturation | 1 | 2000 | 4 | 0.160 |
Why?
| | Interleukin-3 | 1 | 2000 | 23 | 0.160 |
Why?
| | Cell Movement | 2 | 2017 | 950 | 0.160 |
Why?
| | Cytokines | 3 | 2024 | 2079 | 0.160 |
Why?
| | Emergency Responders | 1 | 2021 | 38 | 0.160 |
Why?
| | Immune Evasion | 1 | 2021 | 63 | 0.160 |
Why?
| | Arthritis, Gouty | 1 | 2020 | 13 | 0.160 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 24 | 0.160 |
Why?
| | Cell Line, Tumor | 3 | 2026 | 3538 | 0.160 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2000 | 55 | 0.160 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 66 | 0.160 |
Why?
| | Isomerism | 2 | 2015 | 55 | 0.160 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 68 | 0.160 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2021 | 78 | 0.160 |
Why?
| | Staphylococcal Infections | 1 | 2024 | 396 | 0.160 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2021 | 66 | 0.150 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2000 | 115 | 0.150 |
Why?
| | Gout | 1 | 2020 | 34 | 0.150 |
Why?
| | Arthritis | 1 | 2020 | 97 | 0.150 |
Why?
| | Interleukin-18 | 1 | 2021 | 234 | 0.150 |
Why?
| | Protein Kinase Inhibitors | 1 | 2026 | 982 | 0.150 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2020 | 169 | 0.150 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 125 | 0.150 |
Why?
| | Prescription Drugs | 1 | 2021 | 110 | 0.150 |
Why?
| | Complement C3d | 2 | 2010 | 67 | 0.150 |
Why?
| | Monocarboxylic Acid Transporters | 2 | 2017 | 21 | 0.150 |
Why?
| | Spliceosomes | 2 | 2017 | 54 | 0.140 |
Why?
| | Asparagine | 1 | 2018 | 34 | 0.140 |
Why?
| | Receptors, Complement 3d | 2 | 2010 | 150 | 0.140 |
Why?
| | Static Electricity | 3 | 2014 | 113 | 0.140 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2018 | 15 | 0.140 |
Why?
| | Aspartic Acid | 1 | 2018 | 88 | 0.140 |
Why?
| | Antibodies, Neutralizing | 1 | 2021 | 346 | 0.140 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1998 | 12 | 0.140 |
Why?
| | Interleukin-17 | 1 | 2018 | 121 | 0.130 |
Why?
| | Ribonucleoprotein, U4-U6 Small Nuclear | 1 | 2017 | 10 | 0.130 |
Why?
| | Models, Chemical | 3 | 2016 | 252 | 0.130 |
Why?
| | Intestinal Mucosa | 1 | 2023 | 666 | 0.130 |
Why?
| | Glucose | 2 | 2021 | 1051 | 0.130 |
Why?
| | Psoriasis | 1 | 2018 | 110 | 0.130 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.130 |
Why?
| | Tyrosine | 1 | 1998 | 217 | 0.130 |
Why?
| | Gene Expression | 2 | 2025 | 1461 | 0.130 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2017 | 18 | 0.130 |
Why?
| | Nitrogen Isotopes | 3 | 2012 | 69 | 0.120 |
Why?
| | Spinal Cord Injuries | 1 | 2020 | 238 | 0.120 |
Why?
| | Point Mutation | 2 | 2009 | 232 | 0.120 |
Why?
| | Protein Structure, Quaternary | 3 | 2011 | 106 | 0.120 |
Why?
| | Endothelial Cells | 2 | 2019 | 876 | 0.120 |
Why?
| | Proteolysis | 1 | 2017 | 174 | 0.120 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 144 | 0.120 |
Why?
| | Molecular Chaperones | 1 | 2017 | 200 | 0.110 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 155 | 0.110 |
Why?
| | RNA Splicing | 1 | 2017 | 287 | 0.110 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 266 | 0.110 |
Why?
| | Tumor Burden | 1 | 2017 | 326 | 0.110 |
Why?
| | Structural Homology, Protein | 1 | 2015 | 21 | 0.110 |
Why?
| | Cell Adhesion | 1 | 2017 | 447 | 0.110 |
Why?
| | Mice, Nude | 1 | 2017 | 665 | 0.110 |
Why?
| | RNA Interference | 1 | 2017 | 470 | 0.110 |
Why?
| | Hemorrhagic Fever, Crimean | 1 | 2015 | 11 | 0.110 |
Why?
| | Cell Proliferation | 2 | 2026 | 2497 | 0.110 |
Why?
| | Calcium Signaling | 1 | 2017 | 246 | 0.110 |
Why?
| | Ubiquitin | 1 | 2015 | 84 | 0.110 |
Why?
| | Transfection | 1 | 2017 | 914 | 0.100 |
Why?
| | Histidine | 1 | 2014 | 66 | 0.100 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4565 | 0.100 |
Why?
| | alpha-Synuclein | 1 | 2014 | 47 | 0.100 |
Why?
| | Proline | 1 | 2014 | 79 | 0.100 |
Why?
| | Signal Transduction | 3 | 2022 | 5234 | 0.100 |
Why?
| | Cold Temperature | 1 | 2015 | 207 | 0.100 |
Why?
| | Metabolome | 1 | 2017 | 390 | 0.100 |
Why?
| | Feedback, Physiological | 1 | 2013 | 79 | 0.100 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 6021 | 0.100 |
Why?
| | Escherichia coli | 3 | 2025 | 831 | 0.090 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2014 | 166 | 0.090 |
Why?
| | Hydrogen | 1 | 2012 | 73 | 0.090 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2018 | 992 | 0.090 |
Why?
| | Carbon Isotopes | 1 | 2012 | 143 | 0.090 |
Why?
| | Capsid Proteins | 2 | 2010 | 94 | 0.090 |
Why?
| | HIV-1 | 3 | 2010 | 911 | 0.090 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1041 | 0.090 |
Why?
| | Lipopolysaccharides | 3 | 2021 | 861 | 0.090 |
Why?
| | Protein Transport | 1 | 2013 | 439 | 0.090 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 1244 | 0.090 |
Why?
| | Mice, Transgenic | 3 | 2021 | 2131 | 0.080 |
Why?
| | Molecular Docking Simulation | 2 | 2026 | 120 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 456 | 0.080 |
Why?
| | Aged | 5 | 2022 | 26251 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1429 | 0.080 |
Why?
| | Capsid | 2 | 2002 | 94 | 0.080 |
Why?
| | Metabolomics | 3 | 2021 | 737 | 0.080 |
Why?
| | Sequence Homology, Amino Acid | 3 | 2020 | 382 | 0.080 |
Why?
| | Up-Regulation | 1 | 2013 | 840 | 0.080 |
Why?
| | Receptors, IgE | 1 | 2010 | 43 | 0.080 |
Why?
| | Hydrogen Bonding | 3 | 2009 | 170 | 0.080 |
Why?
| | PII Nitrogen Regulatory Proteins | 1 | 2009 | 1 | 0.080 |
Why?
| | DNA Mutational Analysis | 1 | 2011 | 409 | 0.080 |
Why?
| | Aging | 1 | 2021 | 1983 | 0.080 |
Why?
| | Interleukin-1beta | 2 | 2023 | 394 | 0.080 |
Why?
| | Multigene Family | 1 | 2010 | 209 | 0.080 |
Why?
| | Primary Cell Culture | 2 | 2021 | 172 | 0.070 |
Why?
| | Time Factors | 2 | 2018 | 7079 | 0.070 |
Why?
| | Protein Denaturation | 2 | 2017 | 76 | 0.070 |
Why?
| | Syndecan-1 | 1 | 2009 | 42 | 0.070 |
Why?
| | Glycolysis | 2 | 2021 | 341 | 0.070 |
Why?
| | Circular Dichroism | 2 | 2017 | 149 | 0.070 |
Why?
| | Interferon-alpha | 1 | 2010 | 201 | 0.070 |
Why?
| | Nuclear Proteins | 1 | 2014 | 739 | 0.070 |
Why?
| | Models, Biological | 4 | 2021 | 1758 | 0.070 |
Why?
| | Brain | 1 | 2021 | 2981 | 0.070 |
Why?
| | Adenylate Kinase | 2 | 2005 | 26 | 0.070 |
Why?
| | Protein Engineering | 1 | 2009 | 122 | 0.070 |
Why?
| | Virulence | 2 | 2026 | 287 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 2 | 2001 | 662 | 0.070 |
Why?
| | Protein Isoforms | 1 | 2009 | 388 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 585 | 0.060 |
Why?
| | Parkinson Disease | 1 | 2014 | 614 | 0.060 |
Why?
| | Female | 9 | 2026 | 79080 | 0.060 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2007 | 59 | 0.060 |
Why?
| | Virion | 1 | 2007 | 112 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 1795 | 0.060 |
Why?
| | Acute Lung Injury | 1 | 2010 | 311 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2013 | 1334 | 0.060 |
Why?
| | Calorimetry | 2 | 2017 | 69 | 0.060 |
Why?
| | Pliability | 1 | 2005 | 45 | 0.060 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2591 | 0.060 |
Why?
| | Thrombopoietin | 1 | 2025 | 5 | 0.060 |
Why?
| | Phosphorylation | 2 | 2020 | 1717 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2017 | 533 | 0.050 |
Why?
| | Enzymes | 1 | 2005 | 60 | 0.050 |
Why?
| | Small Molecule Libraries | 1 | 2025 | 113 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2021 | 3121 | 0.050 |
Why?
| | Movement | 1 | 2005 | 290 | 0.050 |
Why?
| | Heme | 1 | 2024 | 90 | 0.050 |
Why?
| | Hydrolases | 1 | 2023 | 42 | 0.050 |
Why?
| | Male | 9 | 2021 | 73014 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2026 | 928 | 0.050 |
Why?
| | Deuterium | 1 | 2023 | 101 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 372 | 0.040 |
Why?
| | Receptors, Interleukin-13 | 1 | 2001 | 2 | 0.040 |
Why?
| | Interleukin-13 Receptor alpha1 Subunit | 1 | 2001 | 2 | 0.040 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 55 | 0.040 |
Why?
| | Receptors, Interleukin-4 | 1 | 2001 | 16 | 0.040 |
Why?
| | Mathematics | 1 | 2002 | 102 | 0.040 |
Why?
| | Organoids | 1 | 2023 | 143 | 0.040 |
Why?
| | Blood Platelets | 1 | 2025 | 380 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2020 | 3633 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2025 | 432 | 0.040 |
Why?
| | Glutathione Disulfide | 1 | 2021 | 30 | 0.040 |
Why?
| | Iron | 1 | 2024 | 359 | 0.040 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.040 |
Why?
| | Macrophage Activation Syndrome | 1 | 2021 | 22 | 0.040 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 51 | 0.040 |
Why?
| | Solutions | 1 | 2001 | 159 | 0.040 |
Why?
| | Maltose-Binding Proteins | 1 | 2000 | 12 | 0.040 |
Why?
| | Microspheres | 1 | 2021 | 142 | 0.040 |
Why?
| | Candida albicans | 1 | 2021 | 62 | 0.040 |
Why?
| | Arthritis, Rheumatoid | 1 | 2010 | 1184 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 169 | 0.040 |
Why?
| | Immunoassay | 1 | 2021 | 108 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2001 | 360 | 0.040 |
Why?
| | Avian Sarcoma Viruses | 1 | 2000 | 4 | 0.040 |
Why?
| | Endopeptidases | 1 | 2000 | 80 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2001 | 207 | 0.040 |
Why?
| | Disulfides | 1 | 2000 | 93 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 326 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 217 | 0.040 |
Why?
| | Motion | 1 | 2020 | 94 | 0.040 |
Why?
| | Peritonitis | 1 | 2020 | 82 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2001 | 434 | 0.040 |
Why?
| | Hemolysis | 1 | 2021 | 242 | 0.040 |
Why?
| | Phosphotyrosine | 1 | 1999 | 38 | 0.040 |
Why?
| | Protein Sorting Signals | 1 | 1999 | 21 | 0.040 |
Why?
| | Homeostasis | 1 | 2023 | 646 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 612 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 179 | 0.040 |
Why?
| | Uric Acid | 1 | 2020 | 167 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2020 | 758 | 0.040 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2019 | 70 | 0.030 |
Why?
| | Erythrocyte Transfusion | 1 | 2021 | 225 | 0.030 |
Why?
| | Hemoglobins | 1 | 2021 | 384 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2024 | 1118 | 0.030 |
Why?
| | Titrimetry | 2 | 2009 | 12 | 0.030 |
Why?
| | Fructose-Bisphosphate Aldolase | 1 | 1998 | 10 | 0.030 |
Why?
| | Methylation | 1 | 2018 | 241 | 0.030 |
Why?
| | Periplasm | 1 | 2017 | 13 | 0.030 |
Why?
| | Binding, Competitive | 1 | 1998 | 185 | 0.030 |
Why?
| | Ultracentrifugation | 1 | 2017 | 49 | 0.030 |
Why?
| | Protein Unfolding | 1 | 2017 | 34 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2021 | 780 | 0.030 |
Why?
| | Middle Aged | 4 | 2021 | 36359 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2218 | 0.030 |
Why?
| | Keratinocytes | 1 | 2018 | 190 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 1998 | 205 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2017 | 87 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2000 | 728 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 15 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2020 | 611 | 0.030 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2017 | 48 | 0.030 |
Why?
| | NF-kappa B | 1 | 2021 | 674 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2021 | 683 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 104 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 2017 | 526 | 0.030 |
Why?
| | Rabbits | 1 | 1998 | 647 | 0.030 |
Why?
| | Adult | 4 | 2021 | 40821 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 728 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 83 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1223 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 721 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2017 | 212 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 255 | 0.030 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 192 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 590 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2017 | 242 | 0.030 |
Why?
| | Buffers | 1 | 2014 | 56 | 0.030 |
Why?
| | Running | 1 | 2017 | 234 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2014 | 81 | 0.030 |
Why?
| | Electrochemistry | 1 | 2014 | 69 | 0.030 |
Why?
| | Neutrophils | 1 | 2020 | 1132 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 58 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 634 | 0.020 |
Why?
| | Skin | 1 | 2018 | 701 | 0.020 |
Why?
| | Magnesium | 1 | 2014 | 155 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 295 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2020 | 4112 | 0.020 |
Why?
| | Rats | 1 | 2020 | 5574 | 0.020 |
Why?
| | Proteomics | 1 | 2018 | 1202 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2455 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4588 | 0.020 |
Why?
| | Lung | 1 | 2024 | 4119 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2910 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2010 | 103 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 22451 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2009 | 150 | 0.020 |
Why?
| | Adaptive Immunity | 1 | 2010 | 172 | 0.020 |
Why?
| | Spectrum Analysis, Raman | 1 | 2008 | 36 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8351 | 0.020 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2007 | 33 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 845 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2007 | 141 | 0.020 |
Why?
| | Drug Delivery Systems | 1 | 2010 | 377 | 0.010 |
Why?
| | Isoenzymes | 1 | 2007 | 294 | 0.010 |
Why?
| | Computer Simulation | 1 | 2009 | 1014 | 0.010 |
Why?
| | Water | 1 | 2008 | 451 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2010 | 884 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14240 | 0.010 |
Why?
| | Stereoisomerism | 1 | 2002 | 102 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2002 | 326 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2000 | 384 | 0.010 |
Why?
| | Models, Structural | 1 | 1999 | 40 | 0.010 |
Why?
| | Drug Design | 1 | 1999 | 179 | 0.010 |
Why?
|
|
Eisenmesser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|